PMID- 34953176
OWN - NLM
STAT- MEDLINE
DCOM- 20220907
LR  - 20220907
IS  - 1744-9987 (Electronic)
IS  - 1744-9979 (Linking)
VI  - 26
IP  - 5
DP  - 2022 Oct
TI  - Peritoneal dialysis for refractory heart failure: A single-center experience.
PG  - 1007-1013
LID - 10.1111/1744-9987.13785 [doi]
AB  - INTRODUCTION: Heart failure (HF) is a disease associated with poor quality of 
      life. Peritoneal dialysis (PD) can be an alternative in the treatment of these 
      patients to overcome fluid overload. The objective of this study is to observe 
      the effects of PD in refractory HF patients. METHODS: We conducted an 
      observational study including 10 patients with refractory congestive HF. PD 
      started solely for fluid overload. Patients' baseline parameters were compared 
      with follow-up parameters. RESULTS: Median age was 57.5 (44.8-64.3) years. Median 
      left ventricular ejection fraction was 20% (18.8-31.3), and all patients had 
      right ventricular dysfunction. Median estimated glomerular filtration rate was 
      51.2 (43.8-101.3) ml/min/1.73 m(2) . Two patients (20%) died during the follow-up 
      period. New York Heart Association (NYHA) functional class decreased 
      significantly from a median of 4 to 2,1 and 1 in the 3rd, 6th, and 12th months, 
      respectively (p </= 0.01 for all from baseline). Number and length of 
      hospitalization decreased significantly after treatment (number from a median of 
      3 to 0, p = 0.013; days from 50.5 to 0, p = 0.028). CONCLUSION: PD significantly 
      reduced NYHA functional class, number and days of hospitalization for HF. It 
      could be a reasonable option in chronic treatment of patients with refractory HF.
CI  - (c) 2021 International Society for Apheresis, Japanese Society for Apheresis, and 
      Japanese Society for Dialysis Therapy.
FAU - Aslan Kutsal, Dilek
AU  - Aslan Kutsal D
AD  - Department of Nephrology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery 
      Training and Research Hospital, Istanbul, Turkey.
FAU - Yildirimturk, Ozlem
AU  - Yildirimturk O
AD  - Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery 
      Training and Research Hospital, Istanbul, Turkey.
FAU - Sungur, Aylin
AU  - Sungur A
AUID- ORCID: 0000-0002-1904-4906
AD  - Department of Cardiology, Sureyyapasa Chest Diseases and Thoracic Surgery 
      Training and Research Hospital, Istanbul, Turkey.
FAU - Sungur, Mustafa A
AU  - Sungur MA
AD  - Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery 
      Training and Research Hospital, Istanbul, Turkey.
FAU - Kayahan, Munire
AU  - Kayahan M
AD  - Department of General Surgery, Haydarpasa Numune Training and Research Hospital, 
      Istanbul, Turkey.
FAU - Gungor, Baris
AU  - Gungor B
AD  - Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery 
      Training and Research Hospital, Istanbul, Turkey.
LA  - eng
PT  - Journal Article
PT  - Observational Study
DEP - 20220113
PL  - Australia
TA  - Ther Apher Dial
JT  - Therapeutic apheresis and dialysis : official peer-reviewed journal of the 
      International Society for Apheresis, the Japanese Society for Apheresis, the 
      Japanese Society for Dialysis Therapy
JID - 101181252
SB  - IM
MH  - *Heart Failure/complications
MH  - Humans
MH  - Middle Aged
MH  - *Peritoneal Dialysis/adverse effects
MH  - Quality of Life
MH  - Stroke Volume
MH  - Ventricular Function, Left
OTO - NOTNLM
OT  - NYHA functional class
OT  - hospitalization
OT  - peritoneal dialysis
OT  - refractory congestive heart failure
EDAT- 2021/12/26 06:00
MHDA- 2022/09/08 06:00
CRDT- 2021/12/25 17:03
PHST- 2021/12/18 00:00 [revised]
PHST- 2021/06/24 00:00 [received]
PHST- 2021/12/22 00:00 [accepted]
PHST- 2021/12/26 06:00 [pubmed]
PHST- 2022/09/08 06:00 [medline]
PHST- 2021/12/25 17:03 [entrez]
AID - 10.1111/1744-9987.13785 [doi]
PST - ppublish
SO  - Ther Apher Dial. 2022 Oct;26(5):1007-1013. doi: 10.1111/1744-9987.13785. Epub 
      2022 Jan 13.